Adenocarcinoma Of Esophagus Not Yet Recruiting Phase 2 Trials for Irinotecan (DB00762)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04150640P2 5-FU, Oxaliplatin & Liposomal Irinotecan (Nal-IRI) in 1st Line Advanced Esophageal & GastricTreatment